Gene · 23013
SPEN: spen family transcriptional repressor
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SPEN: spen family transcriptional repressor. Genes, record 23013. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/23013
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q96T58 | Msx2-interacting protein | 3,664 | 4 | Ensembl, GeneID, HGNC |
Source UniProt
Patents33
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 65127 | Q96T58 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 9677 | Q96T58 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 9938 | Q96T58 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 9938 | Q96T58 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 9677 | Q96T58 | Espacenet |
| JP 2022141755 A | 2022-09-29 | 163 | Q96T58 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 82973 | Q96T58 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 185944 | Q96T58 | Espacenet |
| JP 2019054813 A | 2019-04-11 | 245562 | Q96T58 | Espacenet |
| JP 2017121241 A | 2017-07-13 | 245562 | Q96T58 | Espacenet |
1 to 10 of 33
See all 33 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,290
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SPEN papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 21 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 16 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 6 | 2025 |
| P30CA014089 | University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG) | 4 | 2025 |
| P30CA015083 | Mayo Clinic Comprehensive Cancer Center Support Grant | 4 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 3 | 2025 |
| P30CA046592 | University of Michigan Rogel Cancer Center Support Grant 2023-2028 | 3 | 2025 |
| P30CA086862 | Cancer Center Support Grant | 3 | 2025 |
| R01HG003143 | Structural Annotation of the Human Genome | 3 | 2025 |
| R01MH101221 | Rare Mutations and Autism Spectrum Disorders | 3 | 2025 |
1 to 10 of 1,290Source NIH's project files
See all 1,290 nih grantsPapers1,651
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Amplification-free attomolar sensing of autism biomarkers with MINT-DNA dendrimer hybrids. | Nanoscale | 2026 | 42610809 | PubTator, text mining | PubMed |
| SPEN Inactivation Drives Resistance to Androgen Receptor Pathway Inhibitors in Metastatic Prostate Cancer. | Clin Cancer Res | 2026 | 42594031 | PubTator, text mining | PubMed |
| Integrative Genomic Analysis Reveals Molecular and Clinical Disparities between Bladder and Upper Tract Urothelial Carcinoma in K-MASTER Program. | Cancer Res Treat | 2026 | 42548179 | PubTator, text mining | PubMed |
| SPEN deficiency contributes to the development of orofacial clefts in humans and mice. | Hum Mol Genet | 2026 | 42456047 | PubTator, text mining | PubMed |
| Genetic mutations in neuroendocrine carcinomas of unknown primary. | Otolaryngol Pol | 2026 | 42417420 | PubTator, text mining | PubMed |
| FISH+ is a ready-to-use proximity labeling method for simultaneous RNA visualization and RNA-interacting protein identification. | Commun Biol | 2026 | 42337049 | PubTator, text mining | PubMed |
| Case Report: A rare case of over 45 years' survival in a patient with tonsillar adenoid cystic carcinoma. | Front Oncol | 2026 | 42311271 | PubTator, text mining | PubMed |
| First large-scale screening of Notch biallelic variants implicates novel candidate genes in congenital hypothyroidism. | J Clin Endocrinol Metab | 2026 | 42192612 | PubTator, text mining | PubMed |
| Endothelial RNA polymerase I, which is regulated by SPEN, is a target for improving anti-PD-1 immunotherapy of cancer. | Biochem Pharmacol | 2026 | 42184928 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Tumor Mutational Burden in Prostate Cancer: Multipublic Dataset Analysis. | Clin Genitourin Cancer | 2026 | 42150923 | PubTator, text mining | PubMed |
1 to 10 of 1,651
See all 1,651 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/23013
GET https://conductscience.org/api/genes/v1/23013/patents?page=2